Showing results (1811-1820 of 1,821) with videos related to

Sort By:
Pageof 183
BMC Genomics|December 5, 2021
Discovery of clinically relevant fusions in pediatric cancerStephanie LaHaye, James R Fitch, Kyle J Voytovich, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Translational Psychiatry|February 6, 2014
Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility geneA Ruiz, S Heilmann, T Becker, et al.
Database : the Journal of Biological Databases and Curation|May 26, 2022
A Simple Standard for Sharing Ontological Mappings (SSSOM)Nicolas Matentzoglu, James P Balhoff, Susan M Bello, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
European Journal of Nutrition|November 9, 2019
Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adultsR Cordova, V Knaze, V Viallon, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|February 15, 2001
Comparison of the TEMPO+ ear-level speech processor and the cis pro+ body-worn processor in adult MED-EL cochlear implant usersJ Helms, J Müller, F Schön, et al.
Nucleic Acids Research|November 14, 2022
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseKilannin Krysiak, Arpad M Danos, Jason Saliba, et al.
Genetics|October 6, 2025
Mondo: Integrating Disease Terminology Across CommunitiesNicole A Vasilevsky, Sabrina Toro, Nicolas Matentzoglu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 183